Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 109


Fertility drugs and young-onset breast cancer: results from the Two Sister Study.

Fei C, Deroo LA, Sandler DP, Weinberg CR.

J Natl Cancer Inst. 2012 Jul 3;104(13):1021-7. doi: 10.1093/jnci/djs255. Epub 2012 Jul 6.


Risk of ovarian cancer in women treated with ovarian stimulating drugs for infertility.

Rizzuto I, Behrens RF, Smith LA.

Cochrane Database Syst Rev. 2013 Aug 13;8:CD008215. doi: 10.1002/14651858.CD008215.pub2. Review.


Long-term relationship of ovulation-stimulating drugs to breast cancer risk.

Brinton LA, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Ruggieri D, Trabert B, Lamb EJ.

Cancer Epidemiol Biomarkers Prev. 2014 Apr;23(4):584-93. doi: 10.1158/1055-9965.EPI-13-0996.


Use of fertility drugs and risk of ovarian cancer: results from a U.S.-based case-control study.

Kurta ML, Moysich KB, Weissfeld JL, Youk AO, Bunker CH, Edwards RP, Modugno F, Ness RB, Diergaarde B.

Cancer Epidemiol Biomarkers Prev. 2012 Aug;21(8):1282-92. doi: 10.1158/1055-9965.EPI-12-0426. Epub 2012 Jun 15.


Timing of familial breast cancer in sisters.

Rebora P, Czene K, Reilly M.

J Natl Cancer Inst. 2008 May 21;100(10):721-7. doi: 10.1093/jnci/djn146. Epub 2008 May 13.


Fertility drugs and the risk of breast cancer.

Ricci E, Parazzini F, Negri E, Marsico S, La Vecchia C.

Hum Reprod. 1999 Jun;14(6):1653-5.


Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort.

Brinton LA, Westhoff CL, Scoccia B, Lamb EJ, Trabert B, Niwa S, Moghissi KS.

Hum Reprod. 2013 Oct;28(10):2813-21. doi: 10.1093/humrep/det323. Epub 2013 Aug 13.


Bisphosphonate use after estrogen receptor-positive breast cancer and risk of contralateral breast cancer.

Monsees GM, Malone KE, Tang MT, Newcomb PA, Li CI.

J Natl Cancer Inst. 2011 Dec 7;103(23):1752-60. doi: 10.1093/jnci/djr399. Epub 2011 Oct 21.


Hormone and fertility drug use and the risk of neuroblastoma: a report from the Children's Cancer Group and the Pediatric Oncology Group.

Olshan AF, Smith J, Cook MN, Grufferman S, Pollock BH, Stram DO, Seeger RC, Look AT, Cohn SL, Castleberry RP, Bondy ML.

Am J Epidemiol. 1999 Nov 1;150(9):930-8.


Oral contraceptives and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers.

Narod SA, Dubé MP, Klijn J, Lubinski J, Lynch HT, Ghadirian P, Provencher D, Heimdal K, Moller P, Robson M, Offit K, Isaacs C, Weber B, Friedman E, Gershoni-Baruch R, Rennert G, Pasini B, Wagner T, Daly M, Garber JE, Neuhausen SL, Ainsworth P, Olsson H, Evans G, Osborne M, Couch F, Foulkes WD, Warner E, Kim-Sing C, Olopade O, Tung N, Saal HM, Weitzel J, Merajver S, Gauthier-Villars M, Jernstrom H, Sun P, Brunet JS.

J Natl Cancer Inst. 2002 Dec 4;94(23):1773-9.


Use of fertility drugs and risk of endometrial cancer in an Italian case-control study.

Parazzini F, Pelucchi C, Talamini R, Montella M, La Vecchia C.

Eur J Cancer Prev. 2010 Nov;19(6):428-30. doi: 10.1097/CEJ.0b013e32833d9388.


Effect of reproductive factors on stage, grade and hormone receptor status in early-onset breast cancer.

Largent JA, Ziogas A, Anton-Culver H.

Breast Cancer Res. 2005;7(4):R541-54. Epub 2005 May 16.


Risk of breast cancer among young women: relationship to induced abortion.

Daling JR, Malone KE, Voigt LF, White E, Weiss NS.

J Natl Cancer Inst. 1994 Nov 2;86(21):1584-92.


Risk of cancer after use of fertility drugs with in-vitro fertilisation.

Venn A, Watson L, Bruinsma F, Giles G, Healy D.

Lancet. 1999 Nov 6;354(9190):1586-90.


Infertility, ovulation induction treatments and the incidence of breast cancer--a historical prospective cohort of Israeli women.

Lerner-Geva L, Keinan-Boker L, Blumstein T, Boyko V, Olmar L, Mashiach S, Rabinovici J, Potashnik G, Lunenfeld E, Schenker JG, Shushan A, Fishman A, Cohen I, Vagman I, Lunenfeld B.

Breast Cancer Res Treat. 2006 Nov;100(2):201-12. Epub 2006 May 10.


Breast cancer risk after exposure to fertility drugs.

Lo Russo G, Spinelli GP, Tomao S, Rossi B, Frati L, Panici PB, Vici P, Codacci Pisanelli G, Tomao F.

Expert Rev Anticancer Ther. 2013 Feb;13(2):149-57. doi: 10.1586/era.12.181. Review.


Oral contraceptives and breast cancer risk among younger women.

Brinton LA, Daling JR, Liff JM, Schoenberg JB, Malone KE, Stanford JL, Coates RJ, Gammon MD, Hanson L, Hoover RN.

J Natl Cancer Inst. 1995 Jun 7;87(11):827-35.


Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.

Tworoger SS, Missmer SA, Barbieri RL, Willett WC, Colditz GA, Hankinson SE.

J Natl Cancer Inst. 2005 Apr 20;97(8):595-602.


Ovulation-inducing drugs and ovarian cancer risk: results from an extended follow-up of a large United States infertility cohort.

Trabert B, Lamb EJ, Scoccia B, Moghissi KS, Westhoff CL, Niwa S, Brinton LA.

Fertil Steril. 2013 Dec;100(6):1660-6. doi: 10.1016/j.fertnstert.2013.08.008. Epub 2013 Sep 5.


Breast cancer risk after use of fertility drugs: stimulating new controversy.

Brinton LA.

J Natl Cancer Inst. 2012 Jul 3;104(13):962-4. doi: 10.1093/jnci/djs275. Epub 2012 Jul 6. No abstract available.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk